Mariam El-Zein

Dr. Mariam El-Zein

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2020 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
CMCamila Marconi
Camila Marconi
MEMariam El-Zein
Mariam El-Zein
JRJacques Ravel
Jacques Ravel
Bing MaBing Ma
Bing Ma
MLMoises D. Lima
Moises D. Lima
MSMarcia Guimaraes Silva
Marcia Guimaraes Silva
Background: Composition of the vaginal microbiome is strongly related to a woman's reproductive health and risk of sexually transmitted infections. Ethnoracial, behavioral, and environmental factors can influence microbiome. The Brazilian population is unique in terms of miscegenation of ethnic groups and behavioral characteristics across different regions. We aimed to characterize the vaginal microbiome of women from 5 geographical regions of Brazil. Methods: We sequenced V3–V4 regions of 16S rRNA gene in vaginal samples of 609 reproductive-aged women. We performed logistic regression analyses to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association between sociodemographic and behavioral factors with Lactobacillus-depleted microbiome (community state type [CST] IV). Results: Vaginal samples were grouped into 5 CST: CST I (L. crispatus predominant, 30.5%), CST II (L. gasseri predominant, 4.4%), CST III (Lactobacillus iners predominant, 36.5%), CST IV (Lactobacillus-depleted, 27.4%), and CST V (L. jensenii predominant, 1.2%). Several factors were independently associated with CST IV, such as smoking (OR, 1.80; 95% CI, 1.02–3.18), number of partners (OR, 2.11; 95% CI, 1.20–3.70), and vaginal douching (OR, 2.24; 95% CI, 1.34–3.74). A protective effect was observed for milk/dairy intake (OR, 0.47; 95% CI, 0.27–0.82) and sitz bathing (OR, 0.43; 95% CI, 0.19–0.98). Conclusions: Nearly two thirds of Brazilian women may be at an increased risk for adverse outcomes associated with a vaginal microbiota characterized by the depletion of Lactobacillus or dominance by L. iners, whose protective role has been widely questioned. Several factors related to sexual behavior and intimate hygiene were associated with CST IV.

16 January 2019 in JMIR Research Protocols
Verified
Journal Article
Open access
MEMariam El-Zein
Mariam El-Zein
FCFrançois Coutlée
François Coutlée
PTPierre-Paul Tellier
Pierre-Paul Tellier
MRMichel Roger
Michel Roger
EFEduardo Franco
Eduardo Franco
HGHITCH Study Group
HITCH Study Group
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Human papillomavirus (HPV) epidemiologic research has generally been individual-based, typically focusing on women, with couple-based research mostly consisting of cross-sectional assessment of prevalent HPV infection in both partners. Objective: The HPV Infection and Transmission among Couples through Heterosexual activity (HITCH) study was set up to investigate the transmissibility of HPV among young, recently-formed couples in Montreal, Canada. Methods: HITCH is a longitudinal investigation of HPV transmission in recently-formed heterosexual partnerships initiated within six-month pre-enrollment, a time at which considerable transmission is believed to occur. A total of 549 newly-formed dyads were recruited (2005-2011) from postsecondary institutions, including 502 young women and their male partner. An additional 46 males were enrolled at follow-up, as some women enrolled a subsequent partner at follow-up. Women aged 18-24 were followed for 24 months for acquisition of HPV types not present at enrolment, whereas men returned for a single follow-up visit at month 4, for a sum total of 3,361 clinic visits. The last follow-up visit occurred in January 2014. Extensive sociodemographic, sexual behavioural, and medical history data were collected every 2-4 months using computer-assisted self-administered questionnaires. Participants also provided genital, blood, oral, and hand specimens for HPV assessment. Results: Although in its early analysis stage, HITCH has produced important publications. Findings from HITCH have increased available knowledge about the natural history of HPV transmission and its determinants, provided further evidence regarding oral-oral and oral-genital routes of HPV transmission, and supplied empirically valid epidemiological parameters of HPV transmission to assist mathematical modelers in health economic assessments. HITCH data were made available to several multi-study collaborations evaluating new HPV detection assays and evidence for-or-against HPV type replacement following the introduction of HPV vaccination. Conclusions: HITCH will continue to offer a unique resource for research on HPV transmission. We welcome any opportunities for collaboration. For more information, researchers are invited to contact the principal investigator at eduardo.franco@mcgill.ca. Clinical Trial: NA

31 January 2023 in eLife
Verified
Journal Article
Open access
PTParker Tope`
Parker Tope`
EFEliya Farah
Eliya Farah
RARami Ali
Rami Ali
MEMariam El-Zein
Mariam El-Zein
WMWilson H Miller
Wilson H Miller
EFEduardo Franco
Eduardo Franco
Background: The COVID-19 pandemic has disrupted cancer care, raising concerns regarding the impact of wait time, or ‘lag time’, on clinical outcomes. We aimed to contextualize pandemic-related lag times by mapping pre-pandemic evidence from systematic reviews and/or meta-analyses on the association between lag time to cancer diagnosis and treatment with mortality- and morbidity-related outcomes.Methods: We systematically searched MEDLINE, EMBASE, Web of Science, and Cochrane Library of Systematic Reviews for reviews published prior to the pandemic (1 January 2010–31 December 2019). We extracted data on methodological characteristics, lag time interval start and endpoints, qualitative findings from systematic reviews, and pooled risk estimates of mortality- (i.e., overall survival) and morbidity- (i.e., local regional control) related outcomes from meta-analyses. We categorized lag times according to milestones across the cancer care continuum and summarized outcomes by cancer site and lag time interval.Results: We identified 9032 records through database searches, of which 29 were eligible. We classified 33 unique types of lag time intervals across 10 cancer sites, of which breast, colorectal, head and neck, and ovarian cancers were investigated most. Two systematic reviews investigating lag time to diagnosis reported different findings regarding survival outcomes among paediatric patients with Ewing’s sarcomas or central nervous system tumours. Comparable risk estimates of mortality were found for lag time intervals from surgery to adjuvant chemotherapy for breast, colorectal, and ovarian cancers. Risk estimates of pathologic complete response indicated an optimal time window of 7–8 weeks for neoadjuvant chemotherapy completion prior to surgery for rectal cancers. In comparing methods across meta-analyses on the same cancer sites, lag times, and outcomes, we identified critical variations in lag time research design.Conclusions: Our review highlighted measured associations between lag time and cancer-related outcomes and identified the need for a standardized methodological approach in areas such as lag time definitions and accounting for the waiting-time paradox. Prioritization of lag time research is integral for revised cancer care guidelines under pandemic contingency and assessing the pandemic’s long-term effect on patients with cancer.Funding: The present work was supported by the Canadian Institutes of Health Research (CIHR-COVID-19 Rapid Research Funding opportunity, VR5-172666 grant to Eduardo L. Franco). Parker Tope, Eliya Farah, and Rami Ali each received an MSc. stipend from the Gerald Bronfman Department of Oncology, McGill University.

11 August 2020 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MEMariam El-Zein
Mariam El-Zein
WGWalter Gotlieb
Walter Gotlieb
LGLucy Gilbert
Lucy Gilbert
RHRobert Hemmings
Robert Hemmings
MBMarcel A. Behr
Marcel A. Behr
FGfor the STAIN‐IT Study Group
for the STAIN‐IT Study Group

25 January 2020 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MEMariam El-Zein
Mariam El-Zein
DCDavid Cheishvili
David Cheishvili
WGWalter Gotlieb
Walter Gotlieb
LGLucy Gilbert
Lucy Gilbert
RHRobert Hemmings
Robert Hemmings
FGfor the MARKER study group
for the MARKER study group

28 October 2021 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JMJulia Andrade Pessoa Morales
Julia Andrade Pessoa Morales
CMCamila Marconi
Camila Marconi
MEMariam El-Zein
Mariam El-Zein
JRJacques Ravel
Jacques Ravel
GPGabriel Victor da Silva Pinto
Gabriel Victor da Silva Pinto
MSMarcia Guimaraes Silva
Marcia Guimaraes Silva
Interplay between vaginal microbiome and human papillomavirus (HPV) remains unclear, partly due to heterogeneity of microbiota. We used data from 546 women enrolled in a cross-sectional study in 5 Brazil. We genotyped vaginal samples for HPV and sequenced V3–V4 region of 16S rRNA gene for vaginal microbiome analysis. We used stepwise logistic regression to construct 2 linear scores to predict high-risk HPV (hrHPV) positivity: one based exclusively on presence of individual bacterial taxa (microbiome-based [MB] score) and the other exclusively on participants’ sociodemographic, behavioral, and clinical (SBC) characteristics. MB score combined coefficients of 30 (of 116) species. SBC score retained 6 of 25 candidate variables. We constructed receiver operating characteristic curves for scores as hrHPV correlates and compared areas under the curve (AUC) and 95% confidence intervals (CI). Overall, prevalence of hrHPV was 15.8%, and 26.2% had a Lactobacillus-depleted microbiome. AUCs were 0.8022 (95% CI, .7517–.8527) for MB score and 0.7027 (95% CI, .6419–.7636) for SBC score (P = .0163). The proposed MB score is strongly correlated with hrHPV positivity—exceeding the predictive value of behavioral variables—suggesting its potential as an indicator of infection and possible value for clinical risk stratification.